Section Editor Research Articles

Meet Our Section Editor

Meet Our Section Editor

Meet the Section Editor

Meet the Section Editor

Editorial introductions.

Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

Editorial introduction

Editorial introduction

Editorial introductions.

Current Opinion in Otolaryngology & Head and Neck Surgery was launched in 1993. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of otolaryngology and head and neck surgery are divided into 11 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITOR Cesare PiazzaCesare Piazza, MD, born in Cremona in 1971, has been Full Professor and Chief of the Department of Otorhinolaryngology – Head and Neck Surgery of the University of Brescia, Italy since September 2020. He received his MD degree at the University of Pavia, Italy, in 1996 and completed his residency program in otorhinolaryngology – Head and Neck Surgery in Brescia in 2001. He became Assistant Professor in 2007 and Associate Professor, Chief of the Department of Otorhinolaryngology, Maxillofacial, and Thyroid Surgery of the National Cancer Institute, University of Milan, Italy, in 2017. His clinical and research activities are focused on head and neck oncology, with special emphasis to laryngo-hypopharyngeal, tracheal, oral, thyroid, parotid, sarcoma, laser, and reconstructive microsurgery. Dr Piazza is an active member of the European Laryngological Society since 2000, part of its Scientific Council since September 2010, and President since May 2021. He authored or co-authored 207 papers in peer-reviewed journals as well as 76 book chapters. He delivered 864 proffered papers and invited lectures in national and international Congresses and Courses. He has served as Section Editor of Current Opinion in Otolaryngology & Head and Neck Surgery for the Head and Neck Oncology issue since 2010 and has been a member of the journal's Editorial Board since 2013. He has been a member of the Editorial Board of Frontiers in Oncology since 2016 and Acta Otorhinolaryngologica Italica and Frontiers in Otolaryngology – Head and Neck Surgery since 2017. His surgical activity has been always mainly devoted to head and neck cancer treatment, with more than 6,000 surgical procedures performed in this field (of whom nearly 1200 were free flaps). Alberto PadernoDr Alberto Paderno, MD, born in Brescia in 1987, has been a Staff Member in the Department of Otorhinolaryngology – Head and Neck Surgery at the University of Brescia, Italy, since November 2018. He received his MD degree at the University of Brescia, Italy in 2012 and completed his residency programme in otorhinolaryngology – head and neck surgery in Brescia in 2018. He is currently a PhD candidate in the field of artificial intelligence in medicine. His clinical and research activities focus on head and neck oncology, with particular emphasis on laryngeal and hypopharyngeal cancer, oral malignant and potentially malignant disease, and transoral laser microsurgery. He is involved in various international studies in fields ranging from translational research, biomarkers, oncology, head and neck surgery, and artificial intelligence. He authored or co-authored 78 papers in peer-reviewed journals as well as five book chapters. He has served as Section Editor of Current Opinion in Otolaryngology & Head and Neck Surgery for the Head and Neck Oncology issue, since 2021. He is a member of the Editorial Board of Acta Otorhinolaryngologica Italica and topic Editor in Frontiers in Oncology, since 2020. His surgical activity is mainly focused on head and neck oncology and, in particular, transoral laser microsurgery.

Editorial introductions.

Current Opinion in Neurology was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of neurology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Lawrence J. HirschLawrence J. HirschLawrence J. Hirsch, MD is Professor of Neurology, Chief of the Division of Epilepsy and EEG, and Co-Director of the Comprehensive Epilepsy Center, all at Yale University, USA. He has held leadership positions in the American Clinical Neurophysiology Society (ACNS), American Epilepsy Society, American Academy of Neurology, and the Epilepsy Foundation, and is lead author of the 2012 and 2021 ACNS guidelines on critical care EEG terminology. He is founder and former chair of the Critical Care EEG Monitoring Research Consortium, which now includes more than 50 centers, and co-chair of the medical advisory board of the NORSE Institute. He has been an active researcher throughout his career, having published more than 200 peer-reviewed manuscripts and more than 100 reviews, editorials or book chapters on topics including status epilepticus, all aspects of EEG including intracranial recordings and brain monitoring in the critically ill, brain stimulation, epilepsy surgery, seizure clusters, rescue medications, sudden death in epilepsy (SUDEP), and anti-seizure medication use. He has won multiple teaching awards and is co-author of the first-ever atlas on EEG in critical care, now in its 2nd edition. He continues to see patients in the inpatient and outpatient setting, direct fellowship programs, teach, mentor, and manage a large epilepsy division at a level IV Comprehensive Epilepsy Center. Michael F. WatersMichael F. WatersMichael F. Waters, MD, PhD, is a neurologist, director of both the Neurovascular Division and the Petznick Stroke Center, and a professor in the Department of Neurology at Barrow Neurological Institute, USA. He is board certified in neurology by the American Board of Psychiatry and Neurology with subspecialty board certification in vascular neurology. Dr Waters’ expertise is stroke and neurovascular disease, including signs, symptoms, diagnostics, and treatments. He is a fellow of both the American Academy of Neurology and American Heart Association and a member of the American Neurological Association, American Society of Human Genetics, and the Society of Vascular and Interventional Neurology. Dr Waters received his Masters in genetics from Penn State University in State College, Pennsylvania, USA, and his doctorate in biochemistry and molecular biology from The University of Florida College of Medicine in Gainesville, USA, where he also completed his MD. He completed his residency training at the University of California – Los Angeles Department of Neurology and completed his fellowship in clinical and molecular neurogenetics at Cedars Sinai Medical Center in Los Angeles, USA. Dr Waters’ research studies include genetic mechanisms of stroke, neuroprotection in stroke, stroke treatment, multiple clinical trials investigating stroke treatments, and neurogenetic mechanisms of neuroplasticity.

Editorial introductions.

Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned to a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Matteo BassettiMatteo BassettiMatteo Bassetti is Head of the Infectious Diseases Clinic of the Policlinico San Martino University Hospital in Genoa and Full Professor of Infectious Diseases of the University of Genoa, Italy. Dr Bassetti studied at the University of Genoa School of Medicine and continued his medical education at the Yale University School of Medicine, New Haven, USA with an Infectious Diseases fellowship. Dr Bassetti is Chair of the Critically Ill Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), president of the Italian Society of Anti-infective Therapy (SITA) and member of executive committee for the battle against antimicrobial resistance of the Italian Minister of Health (PNCAR). He is member-elected (2018-2022) of International Council of the Immunocompromised Host Society (ICHS). From 2019, he is member of the council of International Sepsis Forum (ISF). He serves on the editorial board of several prestigious international journals. He is author or co-author of 750 papers (H index 85; 30000 citations) published in International peer-review journals and several chapter's book on antibiotic therapy, fungal infections, antimicrobial resistances, infections in immunocompromised patients and critically ill patients. Wei Shen LimWei Shen LimProfessor Wei Shen Lim is consultant respiratory physician at Nottingham University Hospitals NHS Trust and Honorary Professor of Respiratory Medicine, University of Nottingham, UK. He is Chair of COVID-19 Immunisation on the Joint Committee of Vaccination and Immunisation (JCVI), UK and a member of various national advisory groups including the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) to the Chief Medical Officer for England. He was Chief Investigator of the hibernated ASAP Trial of Dexamethasone in Pandemic Influenza (2012-2022), and co-led the evaluation of Dexamethasone for COVID-19 in the RECOVERY TRIAL He has been involved with the British Thoracic Society (BTS) and the National Institute for Health and Care Excellence (NICE) in the development of various national clinical management guidelines for acute respiratory infections including community acquired pneumonia, pandemic influenza and COVID-19. He developed the CURB-65 severity assessment score for community acquired pneumonia and the BTS community acquired pneumonia care bundle. He was awarded the British Thoracic Society Meritorious Award in 2016 for contributions towards respiratory infections, and in 2021 the Moxon Medal by the Royal College of Physicians (London).

Editorial introductions.

Current Opinion in Obstetrics and Gynecology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of obstetrics and gynecology is divided into ten sections that are reviewed once a year. Each section is assigned one or more Section Editors. They are the leading authorities in their area, who identify the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Deirdre LyellDeirdre LyellDr Lyell is a Professor of Obstetrics and Gynecology in the Division of Maternal-Fetal Medicine at Stanford University, USA, where she serves as the Associate Division Director, Director of the Program in Placental Disorders, and Program Director of the Maternal-Fetal Medicine Fellowship. Dr Lyell is a member of the Child Health Research Institute at Stanford, the March of Dimes Prematurity Research Center at Stanford, and conducts research in clinical obstetrics. From 2013–2016 she served as an alternate P.I. to the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Maternal-Fetal Medicine Unit (MFMU) Network, USA. In 2010 she formed the Program in Placental Disorders at Stanford, a multidisciplinary patient care and research program for women with placenta accreta and cofounded a Placenta Accreta Special Interest Group that meets annually at the Society for Maternal-Fetal Medicine meeting. Dr Lyell earned a Bachelors of Arts and Sciences in History and Biology from Stanford University and a Medical Degree from the George Washington University School of Medicine, USA. She completed residency training in Obstetrics and Gynecology at Brigham and Women's and Massachusetts General Hospitals, USA, and fellowship in maternal-fetal medicine at Stanford University. She is certified by the American Board of Obstetrics and Gynecology in obstetrics and gynecology and maternal-fetal medicine. Mark BoddyMark BoddyDr Mark Boddy received his bachelor's degree from Georgia State University, USA. He received his medical degree from the Medical College of Georgia prior to completing a residency in obstetrics and gynecology at Atlanta Medical Center, USA. He subsequently completed a fellowship in maternal fetal medicine at The George Washington University School of Medicine, USA. He practiced for 17 years in a hospital-based setting while also serving as a Regional Perinatal Director for the State of Georgia. Currently, Dr Boddy is an Associate Clinical Professor at Stanford University School of Medicine, USA and the Medical Director of the Stanford Children's Healthcare Perinatal Diagnostic Center in Salinas, California, USA. His interests include prenatal diagnosis, improving quality of care and patient safety. Martha RodeMartha RodeDr Martha Rode received her bachelor's degree in biology at Harvard University, USA, before attending medical school at the University of California, Los Angeles, USA. She then completed residency and a maternal-fetal medicine fellowship at the University of Pennsylvania in Philadelphia, USA. She has since worked in both academic and hospital-based practices on both the East Coast and Northern California Bay Area in USA. She is currently a Clinical Associate Professor at Stanford Medical School, USA, serving as the Medical Director of the Perinatal Diagnostic Center in Santa Cruz. Her interests include perinatal diagnosis and high-risk obstetrics as well as community physician outreach and continued education. Jane ChuehJane ChuehDr Jane Chueh received her bachelor's degrees in biology and humanities at Stanford University, USA. She attended medical school at University of California San Diego, USA and completed her residency at University of Washington, USA and her fellowships in maternal fetal medicine and clinical genetics at University of California San Francisco, USA. She has worked in both academic and hospital-based practices in the Northern California Bay Area. Currently she is a Clinical Professor at Stanford Medical School, serving as the Director of Prenatal Diagnosis and Therapy at Stanford Children's Health. She enjoys practicing prenatal diagnosis and high-risk obstetrics, collaborating in research projects related to ultrasound and simulation teaching, and mentoring Stanford undergraduates and medical students. Amy VoedischAmy VoedischAmy J Voedisch, MD, MSc, NCMP is a Clinical Associate Professor in the Division of Family Planning, in the Department of Obstetrics and Gynecology at Stanford University, USA. Dr Voedisch attended the Mayo Medical School in Rochester, Minnesota, USA, and completed her OB-GYN residency at Kaiser Permanente Santa Clara, USA. She then went on to a fellowship in family planning at Stanford University, becoming an expert in reproductive health services, with a focus on increasing access to contraception in underserved international areas. She also earned her master's degree in clinical sciences research during her fellowship. Dr Voedisch is an expert in perimenopause and menopause and is a North American Menopause Society Certified Menopause Practitioner (NCMP).

Editorial introductions.

Current Opinion in Anesthesiology was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of anesthesiology is divided into 16 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Catherine M. KuzaCatherine M. KuzaDr Catherine M. Kuza, MD, FASA is an Associate Professor of Anesthesiology in the Department of Anesthesiology, Division of Critical Care at the Keck School of Medicine of the University of Southern California (KSOM USC), Los Angeles, USA. She completed her anesthesiology residency training at the University of Massachusetts School of Medicine in Worcester, MA, USA and went on to complete a critical care fellowship at Brigham and Women's Hospital in Boston, MA, USA. She has been faculty at KSOM USC since 2016, where she served as the Director of Resident Research and Quality Improvement from 2017–2019, and in 2019 became the Director of Trauma Researcher. In 2021 she was appointed Associate Director of the Surgical Intensive Care Unit. Her areas of research include trauma anesthesiology, emergency preparedness and mass casualties, burns, critical care delirium, and post-intensive care unit syndrome. She enjoys teaching and has served as a mentor in research, anesthesiology, and critical care to numerous medical students, residents, and fellows. She has published a number of journal articles and book chapters related to trauma, burns, critical care, and emergency preparedness. She is an active member of numerous professional societies including the American Society of Anesthesiologists (ASA). While serving on the ASA Committee of Trauma and Emergency Preparedness, she has spearheaded several multicentre trauma studies. Edoardo De RobertisEdoardo De RobertisEdoardo De Robertis is Professor of Anaesthesiology at the University of Perugia, Italy, where he coordinates the Division of Anaesthesia, Analgesia, and Intensive Care. He is the Director of the clinical university department of Anaesthesia and Intensive Care and director of the Residency Program and School in Anaesthesia, Intensive Care and Pain. He is President of the European Society of Anaesthesia and Intensive Care (ESAIC) for the two years term 2022–23. Prof Edoardo De Robertis graduated with honour in Medicine and Surgery at the University of Napoli Federico II, Italy, where he completed his anaesthesiology residency. At the University of Lund, Sweden he received his PhD. Leader of a research group at the University Federico II, Italy, and more recently at the University of Perugia, Italy, Prof De Robertis has been involved in the planning, management and coordination of experimental studies in complex animal models and clinical studies on mechanical ventilation. An innovative system of ventilation aimed at the reduction of airway dead space (ASPIDS) was developed. Prof De Robertis has been actively involved in numerous collaboration and research projects with European partners and in the drafting of guidelines of the European Society of Anesthesiology (ESA/IC). He coordinated for Italy the ESA multicentric study PROVHILO and the ESICM consensus study WELPICUS. Prof De Robertis has focused his research activity on mechanical ventilation in critically ill patients and on the management of peri-operative massive bleeding, with particular attention to postpartum haemorrhage. He is also interested in the preoperative evaluation of the obstetric patient, and in the management of neuromuscular block in pelvic laparoscopic surgery.

Problem section

School Science and MathematicsEarly View PROBLEMS Problem section Albert Natian, Corresponding Author Albert Natian Section Editor [email protected] [email protected]Search for more papers by this author Albert Natian, Corresponding Author Albert Natian Section Editor [email protected] [email protected]Search for more papers by this author First published: 06 June 2023 https://doi.org/10.1111/ssm.12594Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issue RelatedInformation

Meet the Section Editor

Meet the Section Editor

Correction to: The CASSISS Randomized Clinical Trial.

HomeStrokeVol. 54, No. 4Correction to: The CASSISS Randomized Clinical Trial Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: The CASSISS Randomized Clinical Trial Originally published27 Mar 2023https://doi.org/10.1161/STR.0000000000000432Stroke. 2023;54:e188This article corrects the followingThe CASSISS Randomized Clinical TrialIn the article by Turan and Psychogios, “The CASSISS Randomized Clinical Trial,” which published online on November 21, 2022, and appeared in the January 2023 issue of Stroke (Stroke.2023;54:286–289. doi: 10.1161/STROKEAHA.122.041096), a correction to the footnotes is needed.The following footnote should appear in the article: Keith Muir, MD, and Gustavo Saposnik, MD, MPH, PhD serve as Section Editors for the Emerging Therapy Critique articles.This correction has been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.041096. Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesThe CASSISS Randomized Clinical TrialTanya N. Turan, et al. Stroke. 2023;54:286-289 April 2023Vol 54, Issue 4 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/STR.0000000000000432PMID: 36972351 Originally publishedMarch 27, 2023 PDF download Advertisement

Meet the Section Editors

Meet the Section Editors

Molecular Microbiology, one health, one planet

Molecular Microbiology is seeking original research and review articles for a special section that will focus on the One Health initiative and the Sustainable Development Goals of the United Nations. These initiatives are geared toward increasing scientific knowledge and developing molecular tools to monitor and control microbial activities with an emphasis on helping the global community tackle infectious diseases, promote sustainable agriculture, and protect the environment. To support research communities working at the intersection of microbiology, health, climate, and sustainable research, Molecular Microbiology is introducing a new section called “One Health Microbiology.” This section will cover a broad range of disciplines, including infectious diseases, molecular biology, environmental sciences, biotechnology, immunology, pharmaceutical sciences, food sciences, social sciences, economics, and multidisciplinary sciences. The aim is to provide a holistic view of the field and offer high-quality, interdisciplinary content that meets the highest standards. The journal is now calling for contributions to create an authoritative collection of articles that will present research, concepts, and challenges related to One Health initiatives. The articles should be of interest to a wide audience, address challenging scientific questions, offer biological or mechanistic insights, propose solutions to existing problems, or provide a perspective on the future of the field. While the journal encourages submissions of original research or review articles, all types of articles will be considered. The initial deadline for submission is July 15, 2023, with a secondary target submission date of September 30, 2023. To submit a manuscript to Molecular Microbiology's “One Health Microbiology” section, authors must follow the Author Guidelines and use the journal's online submission system. During the submission process, authors are asked to clearly indicate that their contribution is intended for this section. All submitted manuscripts will be peer-reviewed according to the journal's publishing policies. Accepted articles will be published online without charge. While authors are not required to pay Article Processing Charges (APCs), they have the option to publish their article as open access. If they choose this option, Wiley may cover the APCs through agreements with institutions and funders globally. Section Editors: Neil Gow, University of Exeter, Exeter, United Kingdom Leah Cowen, University of Toronto, Canada Monica Gandhi, University California San Francisco, United States Nicole De Nisco, University Texas Dallas, United States Jacomine Krijnse Locker, Paul Ehrlich Institut, Germany Friedrich Frischknecht, Heidelberg University, Germany Junior Editors: Daniel Fernando Rojas Tapias, Agrosavia, Mosquera, Colombia Michael Neugent, University Texas Dallas, United States

Editorial introductions.

Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Nancy J. BrownNancy J. BrownNancy J. Brown, MD is the Jean and David W. Wallace Dean of Yale School of Medicine, USA, and the C.N.H. Long Professor of Internal Medicine. Prior to assuming the role of dean at Yale in 2020, Dr Brown served for nine years as the Chair of the Department of Medicine at Vanderbilt University Medical Centre, Tennessee, USA, where she established herself as a national leader in the development of infrastructure to promote the career success of physician-scientists. She founded the Vanderbilt Master of Science in Clinical Investigation program in 2000, served as Associate Dean for Clinical and Translational Scientist Development at Vanderbilt from 2006 to 2010, and as Director of the Division of Clinical Pharmacology from 2009 to 2010. Dr Brown's NIH-funded research focuses on cardiovascular pharmacology and vascular biology in humans. She is particularly interested in understanding the mechanisms of anti-hypertensive and anti-diabetic drugs that are peptidase inhibitors, including the angiotensin-converting enzyme inhibitors, dipeptidyl peptidase 4 inhibitors, and neprilysin inhibitors. Her group has elucidated not only how these drugs decrease inflammation, enhance fibrinolysis (the breakdown of blood clots), and improve glucose homeostasis, but also how they interact with one another and sometimes cause side effects. This understanding leads to optimizing outcomes in patients with hypertension and diabetes. Dr Brown received her A. B. in Molecular Biophysics and Biochemistry from Yale and her MD from Harvard Medical School, USA. She completed her clinical training and a fellowship in clinical pharmacology at Vanderbilt University, Tennessee, USA. Dr Brown is a Fellow of the American Association for the Advancement of Science and a member of the American Society of Clinical Investigation, the Association of American Physicians, the National Academy of Medicine, and the American Academy of Arts and Sciences. She is a Master of the American College of Physicians and a fellow of the Royal College of Physicians. She has served on the National Advisory Research Resources Council and the National Heart, Lung, and Blood Advisory Council of the National Institutes of Health. Dr Brown currently serves on the visiting committee for Harvard Medical School and the External Advisory Board for the Harvard-MIT Health Sciences and Technology program. She is a member of the Scientific Advisory Board of Alnylam Pharmaceuticals. David S. GoldfarbDavid S. GoldfarbDavid S. Goldfarb, MD is Professor of Medicine and Physiology at New York University Grossman School of Medicine, USA. He is the Clinical Chief of the Nephrology Division at New York University Langone Health, and Chief of the Nephrology Section and Director of the Hemodialysis Unit at the New York VA Medical Center in Manhattan, USA. He serves as the Director of the Kidney Stone Prevention Programs at NYU Langone and at New York VA Medical Center, USA. He graduated from Yale College and the Yale School of Medicine, USA, and trained in Internal Medicine at New York VA and New York University, USA, and Nephrology at New York University, USA. He teaches first year renal physiology and renal pathophysiology at NYU, where he has been Teacher of the Year on 3 occasions. Dr Goldfarb is an internationally renowned expert in kidney stone prevention. He is a principal investigator of the Rare Kidney Stone Consortium. Dr Goldfarb is the former President of the NY Society of Nephrology and of the ROCK Society (Research on Calculus Kinetics). He was vice-chair of the American Urological Association's guideline panel, representing the American Society of Nephrology, on Medical Management of Kidney Stones. He is a co-inventor of Moonstone, the first high citrate beverage. He was selected as “Stone Crusher of the Year” in 2014 by the Oxalosis and Hyperoxaluria Foundation and “Nephrologist of the Year” in 2016 by the American Kidney Fund. He has had three calcium oxalate stones.

Editorial introductions.

Editorial introductions.

Editorial Introductions.

Current Opinion in Oncology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Gil AwadaGil AwadaGil Awada (1990) studied medicine at the Vrije Universiteit Brussel (Brussels, Belgium), graduating in 2015, and subsequently started his training in Internal Medicine. In June 2021, he successfully defended his PhD thesis entitled ‘Expanding the application of targeted therapies and immune checkpoint inhibitors in advanced melanoma and recurrent glioblastoma’, under the supervision of Prof. Dr. Bart Neyns. He is currently finishing his residency in Medical Oncology at the Jules Bordet Institute, Belgium. Gil Awada performs clinical and translational research in the field of melanoma, investigating new applications of targeted agents, combination therapies and the use of novel clinical biomarkers (such as circulating tumor DNA and imaging). His work has been presented at national and international congresses and has been published in peer-reviewed journals. Oliver BechterOliver BechterOliver Bechter earned his MD at the University of Innsbruck, Medical School in Austria in 1998. During his residency he did a postdoctoral fellowship at the Department of Cell Biology, UTSouthwestern in Dallas, TX, USA. He earned his PhD in 2005 and is a board-certified Medical Oncologist and Hematologist since 2007. Since 2012 he is working at the University Hospital in Leuven Belgium and is a professor for Oncology at the Department of Oncology from the KU Leuven. His research focus is telomere biology in human malignancies and melanoma biology. His clinical focus is on malignant melanoma and skin cancers and he is principal investigator of several clinical trials with a focus on drug development of new immune-oncology drugs in melanoma. Jana JeschkeJana JeschkeJana Jeschke studied molecular medicine at the University of Erlangen-Nuremberg, Germany, and performed her PhD research at the Johns Hopkins University in Baltimore, USA, in the groups of Prof. Nita Ahuja and Prof. Jim Herman and in collaboration with Prof. Baylin. During this time, she made several important discoveries in the field, including the identification and functional characterization of aberrantly DNA methylated genes in breast cancer and their assessment as novel biomarkers. In 2013, Dr Jeschke moved to Belgium to start a postdoctoral training in the Laboratory of Cancer Epigenetics at Université Libre de Bruxelles (ULB) in Brussels. Under the supervision of her lead mentor Prof. Fuks and his long-time collaborator Prof. Sotiriou, a breast cancer expert from the Jules Bordet Institute in Brussels, she explored changes of various epigenetic modifications on DNA and RNA in breast and other cancers and the clinical relevance of these aberrations for cancer diagnosis and therapy. Her most notable works include the development of an epigenetic immune signature that predicts survival and response to chemotherapy in breast cancer (JCI 2017) and the discovery of m6A mRNA methylation changes in breast cancer and their impact on pathways driving cancer progression and therapy resistance (Nature Cancer 2021). For her research, Dr Jeschke was awarded a postdoctoral fellowship from the Belgian National Fund for Scientific Research (FNRS) in 2014. In 2022, she obtained the mandate of Chercheuse Qualifiée (Associate Professor) from the FNRS to start her own research group at ULB focusing on precision cancer epigenetics. Dr Jeschke is a member of the Belgian Association for Cancer Research (BACR), European Association for Cancer Research (EACR), American Association for Cancer Research (AACR) and Cancer Epigenetics Society (CES) and a consultant for the “Belgian Superior Health Council”. She is an associate editor for the journal of Current Opinion in Oncology and regularly reviews for other journals publishing studies related to cancer and epigenetics.

Editorial introductions.

Current Opinion in Psychiatry was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 13 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Perminder S. SachdevPerminder S. SachdevPerminder S. Sachdev AM, MBBS, MD, FRANZCP, PhD, FAHMS, is Scientia Professor of Neuropsychiatry, Co-Director of the Centre for Healthy Brain Ageing (CHeBA) in the School of Psychiatry, UNSW Sydney, Australia, and Clinical Director of the Neuropsychiatric Institute (NPI) at the Prince of Wales Hospital, Sydney, Australia. He is co-chair of the Australian Dementia Network (ADNeT), and director of the Centre of Research Excellence in Vascular Contributions to Dementia. His major areas of research are drug-induced movement disorders, brain imaging, cognitive ageing and dementia. He has published over 700 peer-reviewed journal papers and six books, including one for lay readers (The Yipping Tiger and Other Tales from the Neuropsychiatric Clinic) and a book of poems (A Migrant's Musings). He was named NSW Scientist of the Year for Biomedical Sciences in 2010. In 2011, he was appointed Member of the Order of Australia (AM) for services to medical research. In 2018, he won the DARF-Yulgilbar Innovation Award for dementia research. In 2022, he was awarded the Ryman Prize for research concept or initiative that has enhanced quality of life for older people. Roma VasaRoma VasaDr Roma Vasa is an internationally recognized developmental neuropsychiatrist and the Director of Psychiatric Services at the Center for Autism and Related Disorders at the Kennedy Krieger Institute. She is an Associate Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. Dr Vasa is co-chair of the Autism and Intellectual Disability Committee of American Academy of Child and Adolescent Psychiatry. Within the field of developmental neuropsychiatry, Dr Vasa specializes in the assessment and treatment of neurodevelopmental disorders and their associated psychiatric conditions, as well as neuropsychiatric outcomes after pediatric traumatic brain injury. Her research focuses on investigating the phenotype and underlying transdiagnostic constructs of anxiety in autism spectrum disorder, notably intolerance of uncertainty. Dr Vasa is committed to training the next generation of psychiatrists, students, and other professionals in developmental neuropsychiatry and has developed innovative educational models in this area. She recently launched the Developmental Neuropsychiatry Scholar Program at the Kennedy Krieger Institute, which provides advanced specialty training to child and adolescent psychiatrists.

Editorial introductions.

Current Opinion in Gastroenterology was launched in 1985. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of gastroenterology is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Chantal HoussetChantal HoussetChantal Housset is Professor of Cell Biology at Sorbone Université, Paris, France, since 2000. She is Course Director of molecular and cellular biology at Sorbonne Université Medical School & Life Science Department. She is Hepatologist in the Reference Center for Inflammatory Biliary Diseases and Auto-immune Hepatitis, in Saint-Antoine Hospital, and of the Rare Liver Disease National Network (FILFOIE). She is the Head of an INSERM-Sorbonne Université Laboratory of translational research on metabolic and biliary diseases of the liver in Centre de Recherche Saint-Antoine (CRSA), Paris. Dr Housset is member of the University National Council (CNU) in Cell Biology. She published 193 articles. Her main scientific contributions relate to the pathophysiology of bile secretion and biliary diseases, the progression of metabolic and biliary diseases towards fibrosis, the origins and functions of myofibroblasts in the liver. Don C. RockeyDon C. RockeyDr Don Rockey completed internship, residency, chief residency, and fellowship at the University of California, San Francisco, USA. He is currently Director of the Medical University of South Carolina Digestive Disease Center. He has active, basic and clinical research interests in liver disease. His basic research focuses on understanding the molecular basis of fibrosis and portal hypertension. His laboratory initially demonstrated that a key player, the hepatic stellate cell, exhibits a contractile phenotype and transforms to a myofibroblast. Further, following liver injury, stellate cells not only produce increases quantities of extracellular matrix, but also exhibit exaggerated contractility, constrict liver sinusoids, and contribute to increased intrahepatic vascular resistance typical of portal hypertension. Dr Rockey also has an active clinical research program, focused on clinical management problems in gastrointestinal bleeding, drug induced liver injury, and chronic liver diseases including complications of portal hypertension. Dr Rockey and colleagues have published some 300 peer reviewed original scientific papers and over 100 editorials, reviews, and book chapters. He has served as a mentor for over 125 trainees, including students, residents, fellows, and junior faculty members - the vast majority of whom have pursued or who are pursuing careers in academic medicine. He has had a number of editorial responsibilities, including as Associate Editor for Hepatology, Liver International, and the Journal of Investigative Medicine, and has served on multiple NIH and other study sections, and editorial boards.

Closing Remarks by Section Editors

Closing Remarks by Section Editors